GlobalData on MSN
BD secures FDA 510(k) clearance for EnCor EnCompass system
"BD secures FDA 510 (k) clearance for EnCor EnCompass system" was originally created and published by Hospital Management, a ...
The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...
Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...
BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...
Pharmaceutical Technology on MSN
BD invests $110m to expand US prefillable syringe production
BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the ...
The FDA clears Becton Dickinson's EnCor EnCompass breast biopsy system, with a U.S. launch planned for early 2026.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2026 Annual Meeting of Shareholders (the "Annual Meeting") on ...
Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...
BD (Becton, Dickinson and Company), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback